Universal Beteiligungs und Servicegesellschaft mbH Has $28.40 Million Position in Cardinal Health, Inc. (NYSE:CAH)

Universal Beteiligungs und Servicegesellschaft mbH raised its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 5.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 206,157 shares of the company's stock after purchasing an additional 10,207 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned 0.09% of Cardinal Health worth $28,402,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. Geode Capital Management LLC lifted its stake in Cardinal Health by 1.9% in the 4th quarter. Geode Capital Management LLC now owns 5,859,132 shares of the company's stock worth $691,145,000 after acquiring an additional 109,273 shares in the last quarter. Invesco Ltd. increased its holdings in shares of Cardinal Health by 4.6% in the 4th quarter. Invesco Ltd. now owns 3,182,514 shares of the company's stock valued at $376,396,000 after purchasing an additional 140,368 shares during the period. Marshall Wace LLP lifted its position in shares of Cardinal Health by 154.6% in the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company's stock worth $372,756,000 after purchasing an additional 1,913,892 shares in the last quarter. Northern Trust Corp boosted its holdings in shares of Cardinal Health by 16.2% during the fourth quarter. Northern Trust Corp now owns 3,037,849 shares of the company's stock worth $359,286,000 after purchasing an additional 422,755 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Cardinal Health by 4.3% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,321,797 shares of the company's stock worth $274,599,000 after purchasing an additional 94,768 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. UBS Group increased their target price on shares of Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a research report on Tuesday, April 29th. Wall Street Zen upgraded Cardinal Health from a "buy" rating to a "strong-buy" rating in a report on Monday, May 5th. Morgan Stanley lifted their price objective on Cardinal Health from $181.00 to $190.00 and gave the company an "overweight" rating in a research report on Wednesday, July 16th. Mizuho raised their price target on Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research note on Monday, March 31st. Finally, Citigroup reissued a "neutral" rating and issued a $170.00 price target (up previously from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Three equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $158.07.

Cardinal Health Price Performance

Shares of NYSE CAH traded down $1.19 during trading hours on Friday, hitting $157.10. 1,212,904 shares of the stock were exchanged, compared to its average volume of 1,857,181. The firm has a market capitalization of $37.49 billion, a P/E ratio of 24.51, a P/E/G ratio of 1.56 and a beta of 0.68. Cardinal Health, Inc. has a one year low of $96.05 and a one year high of $168.44. The company's 50 day moving average is $159.42 and its 200 day moving average is $141.65.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.15 by $0.20. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The company had revenue of $54.88 billion for the quarter, compared to the consensus estimate of $55.33 billion. During the same period last year, the business posted $2.08 earnings per share. The firm's revenue was up .0% compared to the same quarter last year. Research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st were given a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.30%. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date was Tuesday, July 1st. Cardinal Health's dividend payout ratio is currently 31.83%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.